Cargando…

Isobolographic analysis of co-administration of two plant-derived antiplasmodial drug candidates, cryptolepine and xylopic acid, in Plasmodium berghei

BACKGROUND: Increasing resistance to current anti-malarial therapies requires a renewed effort in searching for alternative therapies to combat this challenge, and combination therapy is the preferred approach to address this. The present study confirms the anti-plasmodial effects of two compounds,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ameyaw, Elvis O., Asmah, Kodwo B., Biney, Robert P., Henneh, Isaac T., Owusu-Agyei, Phyllis, Prah, James, Forkuo, Arnold D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885295/
https://www.ncbi.nlm.nih.gov/pubmed/29618354
http://dx.doi.org/10.1186/s12936-018-2283-8
_version_ 1783311955116687360
author Ameyaw, Elvis O.
Asmah, Kodwo B.
Biney, Robert P.
Henneh, Isaac T.
Owusu-Agyei, Phyllis
Prah, James
Forkuo, Arnold D.
author_facet Ameyaw, Elvis O.
Asmah, Kodwo B.
Biney, Robert P.
Henneh, Isaac T.
Owusu-Agyei, Phyllis
Prah, James
Forkuo, Arnold D.
author_sort Ameyaw, Elvis O.
collection PubMed
description BACKGROUND: Increasing resistance to current anti-malarial therapies requires a renewed effort in searching for alternative therapies to combat this challenge, and combination therapy is the preferred approach to address this. The present study confirms the anti-plasmodial effects of two compounds, cryptolepine and xylopic acid and the relationship that exists in their combined administration determined. METHODS: Anti-plasmodial effect of cryptolepine (CYP) (3, 10, 30 mg kg(−1)) and xylopic acid (XA) (3, 10, 30 mg kg(−1)) was evaluated in Plasmodium berghei-infected male mice after a 6-day drug treatment. The respective doses which produced 50% chemosuppression (ED(50)) was determined by iterative fitting of the log-dose responses of both drugs. CYP and XA were then co-administered in a fixed dose combination of their ED(50)s (1:1) as well as different fractions of these combinations (1/2, 1/4, 1/8, 1/16 and 1/32) to find the experimental ED(50) (Z(exp)). The nature of interaction between cryptolepine and xylopic acid was determined by constructing an isobologram to compare the Z(exp) with the theoretical ED(50) (Z(add)). Additionally, the effect of cryptolepine/xylopic acid co-administration on vital organs associated with malarial parasiticidal action was assessed. RESULTS: The Z(add) and Z(exp) were determined to be 12.75 ± 0.33 and 2.60 ± 0.41, respectively, with an interaction index of 0.2041. The Z(exp) was significantly (P < 0.001) below the additive isobole indicating that co-administration of cryptolepine and xylopic acid yielded a synergistic anti-plasmodial effect. This observed synergistic antiplasmodial effect did not have any significant deleterious effect on the kidney, liver and spleen. However, the testis were affected at high doses. CONCLUSION: The co-administration of cryptolepine and xylopic acid produces synergistic anti-malarial effect with minimal toxicity.
format Online
Article
Text
id pubmed-5885295
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58852952018-04-09 Isobolographic analysis of co-administration of two plant-derived antiplasmodial drug candidates, cryptolepine and xylopic acid, in Plasmodium berghei Ameyaw, Elvis O. Asmah, Kodwo B. Biney, Robert P. Henneh, Isaac T. Owusu-Agyei, Phyllis Prah, James Forkuo, Arnold D. Malar J Research BACKGROUND: Increasing resistance to current anti-malarial therapies requires a renewed effort in searching for alternative therapies to combat this challenge, and combination therapy is the preferred approach to address this. The present study confirms the anti-plasmodial effects of two compounds, cryptolepine and xylopic acid and the relationship that exists in their combined administration determined. METHODS: Anti-plasmodial effect of cryptolepine (CYP) (3, 10, 30 mg kg(−1)) and xylopic acid (XA) (3, 10, 30 mg kg(−1)) was evaluated in Plasmodium berghei-infected male mice after a 6-day drug treatment. The respective doses which produced 50% chemosuppression (ED(50)) was determined by iterative fitting of the log-dose responses of both drugs. CYP and XA were then co-administered in a fixed dose combination of their ED(50)s (1:1) as well as different fractions of these combinations (1/2, 1/4, 1/8, 1/16 and 1/32) to find the experimental ED(50) (Z(exp)). The nature of interaction between cryptolepine and xylopic acid was determined by constructing an isobologram to compare the Z(exp) with the theoretical ED(50) (Z(add)). Additionally, the effect of cryptolepine/xylopic acid co-administration on vital organs associated with malarial parasiticidal action was assessed. RESULTS: The Z(add) and Z(exp) were determined to be 12.75 ± 0.33 and 2.60 ± 0.41, respectively, with an interaction index of 0.2041. The Z(exp) was significantly (P < 0.001) below the additive isobole indicating that co-administration of cryptolepine and xylopic acid yielded a synergistic anti-plasmodial effect. This observed synergistic antiplasmodial effect did not have any significant deleterious effect on the kidney, liver and spleen. However, the testis were affected at high doses. CONCLUSION: The co-administration of cryptolepine and xylopic acid produces synergistic anti-malarial effect with minimal toxicity. BioMed Central 2018-04-04 /pmc/articles/PMC5885295/ /pubmed/29618354 http://dx.doi.org/10.1186/s12936-018-2283-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ameyaw, Elvis O.
Asmah, Kodwo B.
Biney, Robert P.
Henneh, Isaac T.
Owusu-Agyei, Phyllis
Prah, James
Forkuo, Arnold D.
Isobolographic analysis of co-administration of two plant-derived antiplasmodial drug candidates, cryptolepine and xylopic acid, in Plasmodium berghei
title Isobolographic analysis of co-administration of two plant-derived antiplasmodial drug candidates, cryptolepine and xylopic acid, in Plasmodium berghei
title_full Isobolographic analysis of co-administration of two plant-derived antiplasmodial drug candidates, cryptolepine and xylopic acid, in Plasmodium berghei
title_fullStr Isobolographic analysis of co-administration of two plant-derived antiplasmodial drug candidates, cryptolepine and xylopic acid, in Plasmodium berghei
title_full_unstemmed Isobolographic analysis of co-administration of two plant-derived antiplasmodial drug candidates, cryptolepine and xylopic acid, in Plasmodium berghei
title_short Isobolographic analysis of co-administration of two plant-derived antiplasmodial drug candidates, cryptolepine and xylopic acid, in Plasmodium berghei
title_sort isobolographic analysis of co-administration of two plant-derived antiplasmodial drug candidates, cryptolepine and xylopic acid, in plasmodium berghei
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885295/
https://www.ncbi.nlm.nih.gov/pubmed/29618354
http://dx.doi.org/10.1186/s12936-018-2283-8
work_keys_str_mv AT ameyawelviso isobolographicanalysisofcoadministrationoftwoplantderivedantiplasmodialdrugcandidatescryptolepineandxylopicacidinplasmodiumberghei
AT asmahkodwob isobolographicanalysisofcoadministrationoftwoplantderivedantiplasmodialdrugcandidatescryptolepineandxylopicacidinplasmodiumberghei
AT bineyrobertp isobolographicanalysisofcoadministrationoftwoplantderivedantiplasmodialdrugcandidatescryptolepineandxylopicacidinplasmodiumberghei
AT hennehisaact isobolographicanalysisofcoadministrationoftwoplantderivedantiplasmodialdrugcandidatescryptolepineandxylopicacidinplasmodiumberghei
AT owusuagyeiphyllis isobolographicanalysisofcoadministrationoftwoplantderivedantiplasmodialdrugcandidatescryptolepineandxylopicacidinplasmodiumberghei
AT prahjames isobolographicanalysisofcoadministrationoftwoplantderivedantiplasmodialdrugcandidatescryptolepineandxylopicacidinplasmodiumberghei
AT forkuoarnoldd isobolographicanalysisofcoadministrationoftwoplantderivedantiplasmodialdrugcandidatescryptolepineandxylopicacidinplasmodiumberghei